Literature DB >> 2541900

Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells.

T Dupressoir1, J M Vanacker, J J Cornelis, N Duponchel, J Rommelaere.   

Abstract

The formation of tumors in adult nude mice from transformed human mammary epithelial cells was drastically inhibited (greater than 80%) both after coinjection of tumoral cells and virus or after a single s.c. injection of parvovirus H-1 at the site of cell implantation prior to tumor formation. Moreover, when injected i.v. in animals bearing preformed tumors, H-1 virus was able to slow down and even in some cases to revert neoplastic growth. Thus, H-1 virus achieved the suppression of implanted tumors of human origin under conditions where the immune antitumor mechanisms of the recipient animals were dramatically impaired. Viral infection was not accompanied by detectable deleterious side effects. Imprints of H-1 virus DNA were found in one residual tumor. Normal human mammary epithelial cells were also compared with homologous transformed cells, either derived from tumors (three lines) or containing simian virus 40 (one line), for their susceptibility to the lytic replication of H-1 virus in vitro. Transformed cell lines were more sensitive to virus-induced killing than secondary cultures of normal cells. Moreover, the former had much greater abilities than the latter to amplify viral DNA and to express the viral nonstructural protein NS-1. Altogether, these results are compatible with the idea that the oncosuppressive activity exerted by H-1 virus may be mediated, at least in part, by virus replication in developing tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541900

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Modulation of minute virus of mice cytotoxic activities through site-directed mutagenesis within the NS coding region.

Authors:  Laurent Daeffler; Rita Hörlein; Jean Rommelaere; Jürg P F Nüesch
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 2.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

Review 3.  Biological response modifiers in the management of patients with breast cancer.

Authors:  D L Longo; L C Hartmann
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

4.  Initiation of transcription from the minute virus of mice P4 promoter is stimulated in rat cells expressing a c-Ha-ras oncogene.

Authors:  P Spegelaere; B van Hille; N Spruyt; S Faisst; J J Cornelis; J Rommelaere
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Exploring the contribution of distal P4 promoter elements to the oncoselectivity of Minute Virus of Mice.

Authors:  Justin Paglino; Erik Burnett; Peter Tattersall
Journal:  Virology       Date:  2006-12-18       Impact factor: 3.616

6.  Transactivation of a cellular promoter by the NS1 protein of the parvovirus minute virus of mice through a putative hormone-responsive element.

Authors:  J M Vanacker; R Corbau; G Adelmant; M Perros; V Laudet; J Rommelaere
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

Review 7.  Retroviral vectors. From laboratory tools to molecular medicine.

Authors:  R G Vile; A Tuszynski; S Castleden
Journal:  Mol Biotechnol       Date:  1996-04       Impact factor: 2.695

8.  The parvoviral capsid controls an intracellular phase of infection essential for efficient killing of stepwise-transformed human fibroblasts.

Authors:  Justin Paglino; Peter Tattersall
Journal:  Virology       Date:  2011-05-20       Impact factor: 3.616

9.  Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.

Authors:  Iván Ventoso; Juan J Berlanga; José M Almendral
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

10.  Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

Authors:  Assia L Angelova; Svitlana P Grekova; Anette Heller; Olga Kuhlmann; Esther Soyka; Thomas Giese; Marc Aprahamian; Gaétan Bour; Sven Rüffer; Celina Cziepluch; Laurent Daeffler; Jean Rommelaere; Jens Werner; Zahari Raykov; Nathalia A Giese
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.